Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.13.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.133NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.466NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.489NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.363NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.95NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.531NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.200NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.299NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.149NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.300NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.179NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.125NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
G.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.438NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.178NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.208NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.197NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.491NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.8 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.338NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.20.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.80NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used